glp-1 approved for sleep apnea Apnea: Drug Zepbound May Help Reduce Symptoms Survey: Providers Want GLP-1s Approved
Description
Ready to Get Started with Elevated Health
PubMed Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition Supports body-composition, lean-mass, and metabolic-risk context
doi: 10.1159/000330447 74 HegedsLShermanSITuttleRMvon ScholtenBJRasmussenSKarsblJDet al
The company does most of its assessment via online questionnaires
In clinical studies, people taking this drug lost 15-22.5% of their body weight over 72 weeks
The short answer is that alcohol tolerance often decreases significantly on these medications
